Why the study?
Despite the common occurrence of incidental pulmonary embolism in cancer patients, optimal management remains unclear.
What are the outcomes and recommended treatments for incidental pulmonary embolism in cancer patients?
What are the outcomes and recommended treatments for incidental pulmonary embolism in cancer patients?
This review summarizes the literature on the outcomes and recommended treatments for incidental pulmonary embolism in cancer patients.
Answers are grounded in this paper and cite their sources.
May guide anticoagulation for incidental PE in cancer; leaves open need for prospective trials to refine regimens.
Patients with cancer have an increased risk of venous thromboembolism (VTE). In addition, due to the growing use of computed tomography scans in these patients and the improved scanners and imaging qualities, many cases of VTE are diagnosed incidentally on images obtained for reasons other than suspicion of VTE. Studies have shown that as many as half of all cancer-related pulmonary embolism (PE) cases could be incidental. Despite the common occurrence, the optimal management of incidental PE in patients with cancer remains unclear. This review will summarize pertinent literature related to incidental PE in the cancer population and discuss their outcomes and recommended treatments.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: